CAH

Market Reaction to Tariffs: Following President Trump's new tariffs, the stock market experienced a significant decline, with major indices like the Dow and S&P 500 dropping nearly 4% and 4.8%, respectively. Jim Cramer suggests focusing on domestic companies with pricing power that can withstand economic slowdowns.

Investment Recommendations: Cramer highlights sectors such as pharmaceuticals, utilities, and telecommunications as promising for investors in the current climate, recommending specific companies like Cardinal Health and Duke Energy, while also noting potential gains for defense contractors due to tariff-related orders.

Stock Performance: Cardinal Health's stock closed at $137.13, down 0.46%, while the S&P 500 gained 0.38%. The stock has increased by 6.65% over the past month, outperforming both the Medical sector and the S&P 500.

Earnings Forecast: The company is set to release its earnings report on May 1, 2025, with an expected EPS of $2.15 and revenue of $55.03 billion. Cardinal Health currently holds a Zacks Rank #2 (Buy) and has a Forward P/E ratio of 17.34, indicating it trades at a premium compared to its industry.

Celsius Holdings Inc Options Trading: Celsius Holdings (CELH) experienced a significant options trading volume of 43,851 contracts, with notable activity in the $34 strike put option expiring March 28, 2025, which saw 7,129 contracts traded.

Cardinal Health Inc Options Trading: Cardinal Health (CAH) also reported high options trading volume of 11,659 contracts, particularly for the $125 strike put option expiring April 17, 2025, with 4,293 contracts traded.

Upcoming Dividend Payments: Cardinal Health, Agilent Technologies, and Encompass Health will trade ex-dividend on April 1, 2025, with respective quarterly dividends of $0.5056, $0.248, and $0.17, leading to expected price adjustments in their stock values.

Dividend Yield Insights: Current estimated annual yields are 1.48% for Cardinal Health, 0.83% for Agilent Technologies, and 0.67% for Encompass Health, indicating the importance of historical dividend stability for future expectations.

Cardinal Health Inc Analysis: Cardinal Health Inc (CAH) has received a high rating of 93% using the Multi-Factor Investor model, indicating strong interest based on its fundamentals and valuation in the Major Drugs industry.

Pim van Vliet's Investment Strategy: The strategy emphasizes low volatility stocks with strong momentum and high net payout yields, highlighting that such stocks can outperform higher volatility counterparts with less risk.

Financial Results Announcement: Cardinal Health will release its third-quarter financial results for fiscal year 2025 on May 1, with a webcast discussion scheduled for 8:30 a.m. Eastern time.

Company Overview: Cardinal Health is a major distributor and manufacturer of pharmaceuticals and medical products, focusing on customer-centric solutions to improve lives.

Revvity's Collaboration with Genomics England: Revvity, Inc. has expanded its partnership with Genomics England to enhance newborn genomic sequencing through the Generation Study, aiming to improve early detection of rare genetic conditions and support personalized healthcare for newborns.

Market Impact and Future Prospects: Despite a recent decline in stock value, this collaboration positions Revvity favorably in the growing field of newborn genomic screening, potentially leading to increased demand for its technologies and long-term revenue growth.

Company Overview: Cardinal Health, Inc. is a major global healthcare solutions provider with a market capitalization of $31.9 billion, operating in over 30 countries and employing more than 48,000 professionals, focusing on pharmaceutical distribution and healthcare logistics.

Stock Performance: CAH stock has seen significant growth, gaining 12.5% over the past three months and reaching an all-time high of $133.11, with analysts rating it as a "Strong Buy" and a mean price target of $142.19, indicating continued bullish momentum amidst market volatility.

Nike and FedEx Earnings: Nike's earnings report showed better-than-expected results, but shares fell nearly 10% in March, while FedEx's adjusted earnings missed expectations, leading to a 5% drop in its stock.

Market Trends and Predictions: Jeffrey Gundlach predicts a 50-60% chance of recession and doubts inflation will reach 2%, while major tech stocks like Apple and Amazon are experiencing significant declines, with Tesla facing its longest losing streak amid recalls.

Company Performance and Market Position: Pacific Biosciences (PacBio) has faced a 28.1% decline in shares over the past six months, despite positive fourth-quarter results and projected growth of 15.7% for 2025, driven by its proprietary sequencing technologies and expanding product portfolio.

Challenges Ahead: The company is experiencing longer purchasing cycles due to macroeconomic concerns and funding uncertainties, particularly affecting sales of its high-cost Revio sequencing system, which could limit near-term revenue growth amidst geopolitical risks and economic pressures.

Market Performance: Major US stock indexes, including the S&P 500 and Nasdaq, closed down due to concerns over US trade policies and economic momentum, despite some positive economic reports on housing starts and manufacturing production.

Geopolitical and Economic Factors: Tensions in the Middle East and recent tariff increases by President Trump are contributing to market volatility, while investors have significantly reduced their stock holdings, leading to a rise in cash levels.

Reflection on the Past: The author recalls the significant moment two years ago when the "Magnificent Seven" emerged, coinciding with the collapse of Silicon Valley Bank while he was in Florida.

Personal Experience: Amidst the chaos, the author humorously shares his experience of buying makeup at Target to prepare for a Zoom call, highlighting the blend of personal and professional challenges during that time.

ETF Analysis: The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has an implied analyst target price of $110.63, indicating a potential upside of 10.69% from its recent trading price of $99.94.

Stock Performance Insights: Notable underlying holdings such as A O Smith Corp, Cardinal Health, and Franklin Resources show significant upside potential based on analysts' target prices, raising questions about the validity of these targets amidst market conditions.

New Board Members: Cardinal Health has elected Robert Musslewhite and Sudhakar Ramakrishna as independent directors, effective March 7, 2025, bringing extensive experience in healthcare technology and cybersecurity to the board.

Leadership Insights: The Chairman and CEO of Cardinal Health expressed confidence that Musslewhite's and Ramakrishna's backgrounds will significantly contribute to navigating complex business environments and driving innovation within the company.

Ulta Beauty Options Trading: Ulta Beauty Inc experienced significant options trading with 4,610 contracts, particularly for the $360 strike call option expiring March 07, 2025, indicating strong interest in this stock.

Cardinal Health Options Activity: Cardinal Health, Inc. saw a high volume of 10,980 contracts traded, especially for the $125 strike put option expiring March 21, 2025, reflecting notable market activity.

Florida's Data Request: The Florida Office of Insurance Regulation is requesting detailed pharmacy claims data from pharmacy benefit managers (PBMs), including personal information such as names, birth dates, and medication details.

Privacy Concerns: A spokesperson for the Florida OIR stated that any privacy issues should be directed to health-care insurance companies, which have previously experienced significant data breaches.

Cardinal Health Options Activity: Cardinal Health, Inc. (CAH) has seen a significant options trading volume of 14,315 contracts today, with notable activity in the $125 strike put option expiring March 21, 2025, which accounted for 2,540 contracts.

Digimarc Options Activity: Digimarc Corp (DMRC) reported an options volume of 816 contracts today, particularly highlighted by the $40 strike call option expiring March 21, 2025, with 505 contracts traded.

Elliott Investment Management Holdings: As of December 31, 2024, Elliott Investment Management disclosed changes in its portfolio, exiting positions in Cardinal Health and Utilities Select Sector SPDR Fund, while increasing stakes in CorMedix and HDFC Bank, and reducing holdings in NRG Energy and Southwest Airlines.

Top Holdings: The fund's top holdings included Triple Flag, Southwest Airlines, Suncor, Pinterest, and NRG Energy, reflecting a strategic adjustment in their investment approach.

Nvidia's Financial Strength Ranking: Nvidia achieved the highest increase in financial strength scores among the latest Management Top 250, followed by Progressive and GoDaddy.

Ranking Methodology: The Management Top 250 ranking evaluates companies based on Peter Drucker's principles across five categories: customer satisfaction, innovation, social responsibility, employee engagement and development, and financial strength, using a statistical model developed by Claremont Graduate University’s Drucker Institute.

Company Overview and Market Performance: Cardinal Health, Inc., based in Dublin, Ohio, has a market cap of $30.8 billion and operates globally with over 48,000 employees. The company's stock has outperformed the broader market in 2025, gaining 7.7% year-to-date, while its annual growth is at 20.5%, compared to the S&P 500's 2.5% YTD increase.

Financial Results and Analyst Ratings: Despite a 3.8% decline in quarterly revenues due to a large customer contract expiration, Cardinal Health reported better-than-expected Q2 results with adjusted EPS rising 2.1%. Analysts have upgraded their ratings on CAH stock to a "Strong Buy," with a mean price target suggesting a potential upside of 10.6% to 22.5%.